Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Campbell, Ph.D.(4.8%)
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(2.0%),Citadel Advisors LLC(1.9%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(4.1%),Tighe Reardon(3.0%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bregua Corporation(5.8%)
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(7.8%),Tighe Reardon(4.8%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Lichter Jay
Janux Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(8.9%),Tighe Reardon(5.5%), etc.
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(19.99%),Peter Kolchinsky(19.99%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Avalon Ventures XI, L.P.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Avalon Ventures XI, L.P.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DiRaimondo Thomas
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
No Data
No Data